免疫层析筛查试剂盒快速床旁评估急性咖啡因中毒血清咖啡因浓度:分析与诊断性能评价
该前瞻性单中心研究纳入26例疑似急性咖啡因中毒患者,于2018至2025年间提供40份血清样本,将Multi-Drug Rapid Test Cassette试剂盒(CAF10000 + CAF50000)的反应模式与液相色谱-串联质谱测定的血清咖啡因浓度进行比较。结果显示,使用未稀释血清时,试剂盒反应模式与预设的三个浓度区间(<10、10-50和>50 µg/mL)总体一致;浓度较高时两条试纸条均保持阳性,限制进一步区分;当估计未稀释浓度超过约80 µg/mL时,即使五倍稀释后两条试纸条仍保持阳性,该观察为探索性。未观察到与咖啡因代谢物或常见同服药物的交叉反应,血清咖啡因在所有测试储存条件下保持稳定。作者结论为该试剂盒无需分析仪器即可将血清咖啡因浓度分类至预设区间,需进一步研究评估这些分析发现的临床相关性。
要点
- 在26例疑似急性咖啡因中毒患者的40份血清样本中,Multi-Drug Rapid Test Cassette试剂盒使用未稀释血清时反应模式与<10、10-50和>50 µg/mL三个预设区间总体一致。
- 当估计未稀释浓度超过约80 µg/mL时,两条试纸条即使五倍稀释后仍保持阳性,无法进一步区分,该观察为探索性。
- 未观察到试剂盒与咖啡因代谢物或常见同服药物发生交叉反应,提示分析特异性良好。
- 血清咖啡因浓度在所有测试储存条件下保持稳定。
- 作者结论为该试剂盒无需分析仪器即可将血清咖啡因浓度分类至预设区间,需进一步研究评估这些分析发现的临床相关性。
适用人群与场景
- 疑似急性咖啡因中毒的患者,共26例,2018至2025年间提供40份血清样本。
诊断标准与关键阈值
- 使用未稀释血清时,Multi-Drug Rapid Test Cassette试剂盒反应模式与预设三个血清咖啡因浓度区间总体一致:<10、10-50和>50 µg/mL。
- 当估计未稀释血清咖啡因浓度超过约80 µg/mL时,两条试纸条即使五倍稀释后仍保持阳性,无法进一步区分(该观察为探索性)。
研究设计与关键结果
- 前瞻性单中心研究,纳入26例疑似急性咖啡因中毒患者,共40份血清样本,将Multi-Drug Rapid Test Cassette试剂盒反应模式与液相色谱-串联质谱测定的血清咖啡因浓度进行比较。
- 使用未稀释血清时,试剂盒反应模式与预设三个浓度区间(<10、10-50和>50 µg/mL)总体一致;浓度较高时两条试纸条均保持阳性,限制进一步区分。
- 当估计未稀释浓度超过约80 µg/mL时,两条试纸条即使五倍稀释后仍保持阳性,该观察为探索性。
- 未观察到与咖啡因代谢物或常见同服药物的交叉反应。
- 血清咖啡因浓度在所有测试储存条件下保持稳定。
证据类型、等级与局限
- 证据类型:前瞻性单中心研究。
- 作者结论:该试剂盒无需分析仪器即可将血清咖啡因浓度分类至预设区间,需进一步研究评估这些分析发现的临床相关性。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该试剂盒无需分析仪器即可在床旁将未稀释血清咖啡因浓度归入<10、10-50和>50 µg/mL三个预设区间,且与代谢物及常见同服药物无交叉反应。
- 当估计未稀释浓度超过约80 µg/mL时,两条试纸条即使五倍稀释后仍保持阳性,无法进一步区分,该观察为探索性。
- 作者结论指出需进一步研究评估这些分析发现的临床相关性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Severe caffeine poisoning can be life-threatening, and rapid identification of toxic or potentially lethal serum caffeine concentrations may provide additional information. However, rapid quantitative analysis using advanced techniques is often unavailable in emergency settings. The Multi-Drug Rapid Test Cassette (CAF10000 + CAF50000), is an instrument-free immunochromatographic assay for the detection of caffeine. This study evaluated the diagnostic performance of the Multi-Drug Rapid Test Cassette kit in patients with acute caffeine poisoning.
METHODS: In this prospective single-centre study, 26 patients with suspected acute caffeine poisoning provided 40 serum samples between 2018 and 2025. The Multi-Drug Rapid Test Cassette kit reaction patterns were compared with serum caffeine concentrations measured by liquid chromatography-tandem mass spectrometry. Additional analysis included the evaluation of cross-reactivity with caffeine metabolites and commonly co-ingested drugs, as well as assessment of serum caffeine stability under different storage conditions.
RESULTS: Using undiluted serum, the Multi-Drug Rapid Test Cassette kit reaction patterns were generally consistent with classification into three predefined ranges: <10, 10-50 and >50 µg/mL. At higher concentrations, both test strips remained positive, limiting further discrimination. When estimated undiluted concentrations exceeded approximately 80 µg/mL, both test strips remained positive even after fivefold dilution. This observation was exploratory. No cross-reactivity was observed with caffeine metabolites or commonly co-ingested drugs. Serum caffeine concentrations remained stable under all tested storage conditions.
DISCUSSION: The Multi-Drug Rapid Test Cassette kit demonstrated the ability to categorize serum caffeine concentrations into predefined ranges and showed no interference from metabolites or co-ingested drugs, suggesting good analytical specificity.
CONCLUSIONS: The Multi-Drug Rapid Test Cassette kit was able to classify serum caffeine concentrations into predefined ranges without analytical instrumentation. Further studies are warranted to evaluate the clinical relevance of these analytical findings.
参考来源
- Yamamoto R, Saito T, Tsuji T, et al. Rapid bedside assessment of serum caffeine concentrations using an immunochromatographic screening kit: evaluation of analytical and diagnostic performance in acute caffeine poisoning. Clin Toxicol (Phila). 2026. PMID: 42290612. doi:10.1080/15563650.2026.2675035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。